z-logo
Premium
Gold nanoparticle‐aided brachytherapy with vascular dose painting: Estimation of dose enhancement to the tumor endothelial cell nucleus
Author(s) -
Ngwa Wilfred,
Makrigiorgos G. Mike,
Berbeco Ross I.
Publication year - 2012
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.3671905
Subject(s) - brachytherapy , dosimetry , medical physicist , medical imaging , colloidal gold , medicine , nuclear medicine , nucleus , nanoparticle , medical physics , radiology , materials science , radiation therapy , nanotechnology , psychiatry
Purpose: Theoretical microdosimetry at the subcellular level is employed in this study to estimate the dose enhancement to tumor endothelial cell nuclei, caused by radiation‐induced photo/Auger electrons originating from gold nanoparticles (AuNPs) targeting the tumor endothelium, during brachytherapy. Methods: A tumor vascular endothelial cell (EC) is modeled as a slab of 2 μm (thickness) × 10 μm (length) × 10 μm (width). The EC contains a nucleus of 5 μm diameter and thickness of 0.5–1 μm, corresponding to nucleus size 5%–10% of cellular volume, respectively. Analytic calculations based on the electron energy loss formula of Cole were carried out to estimate the dose enhancement to the nucleus caused by photo/Auger electrons from AuNPs attached to the exterior surface of the EC. The nucleus dose enhancement factor (nDEF), representing the ratio of the dose to the nucleus with and without the presence of gold nanoparticles was calculated for different AuNP local concentrations. The investigated concentration range considers the potential for significantly higher local concentration near the EC due to preferential accumulation of AuNP in the tumor vasculature. Four brachytherapy sources: I‐125, Pd‐103, Yb‐169, and 50 kVp x‐rays were investigated. Results: For nucleus size of 10% of the cellular volume and AuNP concentrations ranging from 7 to 140 mg/g, brachytherapy sources Pd‐103, I‐125, 50 kVp, and Yb‐169 yielded nDEF values of 5.6–73, 4.8–58.3, 4.7–56.6, and 3.2–25.8, respectively. Meanwhile, for nucleus size 5% of the cellular volume in the same concentration range, Pd‐103, I‐125, 50 kVp, and Yb‐169 yielded nDEF values of 6.9–79.2, 5.1–63.2, 5.0–61.5, and 3.3–28.3, respectively. Conclusions: The results predict that a substantial dose boost to the nucleus of endothelial cells can be achieved by applying tumor vasculature‐targeted AuNPs in combination with brachytherapy. Such vascular dose boosts could induce tumor vascular shutdown, prompting extensive tumor cell death.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here